[CRVS] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
19-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 45.99%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -27,029 -41,307 -43,241 -5,995 -46,672 -46,939 -55,663 -11.33%
Tax 0 8,742 -5,041 -1,172 -2,925 2,283 -842 -
NP -27,029 -50,049 -38,200 -4,823 -43,747 -46,939 -55,663 -11.33%
Tax Rate - - - - - - - -
Total Cost 27,029 50,049 38,200 4,823 43,747 46,939 55,663 -11.33%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.56 -1.08 -0.91 -0.16 -1.49 -1.71 -2.72 -23.14%
EPS Diluted -0.56 -1.08 -0.91 -0.16 -1.49 -1.71 -2.72 -23.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.